US Patent 10501541 Single domain antibodies targeting CD1d
All edits
Edits on 9 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 4 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 9 Dec, 2023
Golden AI
Edits made to:
Article (+508 characters)
Article
Patent abstract
The invention relates to compounds, in particular polypeptides that specifically bind to the non-classical MHC protein CD1d and modulate CD1d-mediated biological functions. The invention in particular relates to such compounds and polypeptides comprising or consisting of at least one single domain antibody, and wherein at least one single domain antibody specifically binds to CD1d. Also provided is for methods and use employing such compounds, polypeptides and/or single-domain antibodies.
Edits on 2 Apr, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
105015410
Date of Patent
December 10, 2019
0Patent Application Number
155464060
Date Filed
January 27, 2016
0Patent Primary Examiner
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
105015410
Date of Patent
December 10, 2019
0Patent Application Number
155464060
Date Filed
January 27, 2016
0Patent Primary Examiner
Edits on 31 Jan, 2022
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 10501541 Single domain antibodies targeting CD1d
Infobox
Is a
Patent jurisdiction
Patent number
10501541
Date of patent
December 10, 2019
Patent application number
15546406
Date Filed
January 27, 2016
Patent primary examiner
Find more entities like US Patent 10501541 Single domain antibodies targeting CD1d
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.